United States · 
Who invested in Symbiomix Therapeutics?
Symbiomix Therapeutics's investors include OrbiMed, F-Prime Capital, Square 1 Bank and HBM Partners.
United States · Series A startup
Who invested in Symbiomix Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$41Mraised across 1 round since 2015, from 1 source
- Latest round
- Series A, $41MMay 2015
- Investors
- 4
The rounds
- May 2015
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Symbiomix Therapeutics
How much has Symbiomix Therapeutics raised?
Symbiomix Therapeutics has raised $41M across 1 round since 2015.
When did Symbiomix Therapeutics last raise?
Symbiomix Therapeutics's most recent round was a Series A of $41M in May 2015.
What was Symbiomix Therapeutics's biggest round?
Its most recent round, $41M in May 2015, is also its largest on record.
Who backed Symbiomix Therapeutics first?
Symbiomix Therapeutics's first round on record, in May 2015, was backed by OrbiMed, F-Prime Capital and Square 1 Bank and 1 others.
What stage is Symbiomix Therapeutics at?
Symbiomix Therapeutics's latest named round is a Series A, in May 2015.
Where is Symbiomix Therapeutics based?
Symbiomix Therapeutics is based in the United States.
Companies like Symbiomix Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.